Patents Assigned to Peking University
  • Patent number: 12019206
    Abstract: The present discloses a simulation device and simulation method for liquid sulfur-gas-water multiphase flow and use thereof in a high-temperature and high-pressure gas reservoir with high sulfur content.
    Type: Grant
    Filed: December 21, 2023
    Date of Patent: June 25, 2024
    Assignees: Peking University, China University of Petroleum (East China)
    Inventors: Tong Li, Yongsheng Ma, Caili Dai, Guang Zhao, Qian Li, Daqian Zeng, Ning Sun
  • Patent number: 12006551
    Abstract: A miRNA marker for the treatment and/or diagnosis of Alzheimer's disease (AD), and the miRNA marker is a miRNA23 cluster. The miRNA23 cluster is used in the diagnosis and treatment of AD. The expression of the miRNA23 cluster is detected using primers for the microRNA marker through AD model cells, AD model animals and natural aging animals, and blood of AD patients, and it is found that the expression of the miRNA23 cluster is significantly reduced during the progression of AD, which reduces neuronal apoptosis by inhibiting the GSK-3?-mediated tau protein phosphorylation. Therefore, the miRNA23 cluster can be used as a novel biomarker and therapeutic target for the early, non-invasive diagnosis and treatment of AD.
    Type: Grant
    Filed: July 15, 2022
    Date of Patent: June 11, 2024
    Assignee: Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking University
    Inventors: Rui Liu, Zhuorong Li, Li Zeng, Ting Sun, Mimin Liu, Junxia Zhang
  • Patent number: 11997736
    Abstract: A connection establishment method includes a terminal device obtaining historical data of a multipath transmission control protocol (MPTCP) connection established between the terminal device and an application server. The historical data includes a data transmission delay of a transmission control protocol (TCP) connection corresponding to a Wi-Fi network and a data transmission delay of a TCP connection corresponding to a cellular network. The terminal device determines, based on the historical data, that the data transmission delay of the TCP connection corresponding to the cellular network is less than or equal to the data transmission delay of the TCP connection corresponding to the Wi-Fi network, and establishes a first TCP connection to the application server through an interface of the cellular network; and after the first TCP connection is successfully established, the terminal device establishes a second TCP connection to the application server through an interface of the Wi-Fi network.
    Type: Grant
    Filed: November 30, 2019
    Date of Patent: May 28, 2024
    Assignees: Huawei Technologies Co., Ltd., Peking University
    Inventors: Hao Wang, Songping Yao, Chenren Xu, Fanzhao Wang, Xingmin Guo, Xiangli Li, Zhiyu Chen
  • Patent number: 11982633
    Abstract: The present disclosure provides a method for analyzing the signal of a neutral atom imaging unit, including: preparing a neutral atom imaging unit, which includes a semiconductor detector array and modulation grids disposed at intervals in front of the semiconductor detector array; preparing a neutral atom source plane, energetic neutral atoms emitted by the neutral atom source plane are received by the semiconductor detector array after passing through the modulation grids, and the modulation grids form a projection on the semiconductor detector array; obtaining a response function of the imaging unit according to the projection; calculating the data signal obtained by the neutral atom imaging unit; and performing inversion imaging on the neutral atom emission source according to the response function of the imaging unit and the data signal. The method well inverts the neutral atom emission source to obtain the intensity and size of the neutral atom emission source.
    Type: Grant
    Filed: November 9, 2020
    Date of Patent: May 14, 2024
    Assignee: Peking University
    Inventors: Yongfu Wang, Qiugang Zong, Linghua Wang, Hongfei Chen, Hong Zou, Xiangqian Yu, Weihong Shi, Lyu Zhou
  • Patent number: 11965864
    Abstract: A quantitative source apportionment method based on nontarget high-resolution mass spectrometry (HRMS) data of pollution sources and pollution receptors includes: acquiring samples of pollution sources and receptors, pre-processing samples to extract trace organic pollutants; acquiring chromatography-HRMS nontarget data; pre-processing raw data to obtain a HRMS dataset including a mass-to-charge ratio, a retention time, and a peak area; determining a source-sink relationship based on positions of pollution sources and receptors; constructing an input matrix by combining the HRMS dataset and using each sink as a group; adopting an expectation-maximization method or a Bayesian method to calculate contribution of each source based on a standardized input matrix. Beneficial effects at least include the follows.
    Type: Grant
    Filed: August 14, 2023
    Date of Patent: April 23, 2024
    Assignee: Peking University
    Inventors: Weiling Sun, Yitao Lyu, Qian Chen, Jinren Ni
  • Patent number: 11967456
    Abstract: A device and method for preparing a thermosetting bonded magnet are provided, the device includes a compressed air glue feeding tank and a composite-function mold. A feeding end of the compressed air glue feeding tank is connected to the composite-function mold. The composite-function mold includes a housing, the housing is disposed at an upper end and a lower end of the composite-function mold, and the housing includes a polytetrafluoroethylene upper cover and a polytetrafluoroethylene lower cover; the polytetrafluoroethylene upper cover and the polytetrafluoroethylene lower cover are respectively disposed at the upper end and the lower end of composite-function mold. The method uses a silica gel material as a binder for anisotropic magnets, and the selected raw materials and process are suitable for quickly obtaining a uniform magnet slurry. The curing process is controllable, and there is no organic solvent or heating during the mixing process.
    Type: Grant
    Filed: August 14, 2023
    Date of Patent: April 23, 2024
    Assignee: Peking University
    Inventors: Shunquan Liu, Jinbo Yang, Jingzhi Han, Qing Xu
  • Patent number: 11946007
    Abstract: A natural gas separation and purification and mercury collection system for oil and gas wells includes a cyclone separator, a condensation purification and separation mechanism, pressure buffer mechanisms, mercury collection and separation mechanisms, and natural gas storage tanks. An inlet end of the cyclone separator is communicated with an external gas source through a pressure buffer mechanism, and an outlet end of the cyclone separator is communicated with the condensation purification and separation mechanism through a pressure buffer mechanism. The condensation purification and separation mechanism is communicated with the mercury collection and separation mechanism through a pressure buffer mechanism. The mercury collection and separation mechanism is communicated with the natural gas storage tank through a guide tube. A method of use of the natural gas separation and purification and mercury collection system includes gas collection, gas purification, mercury separation, and mercury analysis.
    Type: Grant
    Filed: November 24, 2023
    Date of Patent: April 2, 2024
    Assignee: Peking University
    Inventors: Quanyou Liu, Pengpeng Li, Jiarun Liu
  • Publication number: 20240085362
    Abstract: The present disclosure provides a method for improving stability of an electrochemical sensor. The method includes the following steps: S1, manufacturing an electrochemical sensor; S2, immobilizing a biosensitive molecular enzyme on a working electrode of the electrochemical sensor; S3, setting a immobilization agent on a surface of the biosensitive molecular enzyme; and S4, adding a protective film on a surface of the immobilization agent, such that the protective film is deposited on the working electrode to improve the stability of the electrochemical sensor. In the present disclosure, glutaraldehyde (GA), polyvinyl alcohol (PVA), and polyethylene glycol (PEG), or polyaniline (PANI), the GA, the PVA, the PEG, and polyurethane (PU) are arranged on a surface of the biosensitive molecular enzyme. Therefore, the surface of the biosensitive molecular enzyme forms a composite protective film, which reduces a probability of direct exposure of an enzyme layer to the air.
    Type: Application
    Filed: July 27, 2023
    Publication date: March 14, 2024
    Applicant: Peking University
    Inventor: Yue CUI
  • Patent number: 11897920
    Abstract: RVDs with recognition preferences for 5mC, 5hmC and 6 mA and different binding properties to these epigenetic modifications are identified in this present invention. Methylation-dependent gene activation, efficient genome editing, targeted detection of 5hmC and other applications can be achieved by using these RVDs. The present invention therefore provides an isolated DNA binding polypeptide containing TALEs, a fusion protein, a polynucleotide, a vector comprising the polynucleotide and a host cell, and the use of the protein comprising TALE repeats domain in the preparation of a reagent for detecting a methylated base in a target sequence of a gene of interest, as well as a method for targeting and binding to a target sequence of a gene of interest in a cell.
    Type: Grant
    Filed: August 4, 2017
    Date of Patent: February 13, 2024
    Assignees: Peking University, Edigene Inc.
    Inventors: Wensheng Wei, Chengqi Yi, Yuan Zhang, Shengjie Guo, Chenxu Zhu, Lulu Liu
  • Patent number: 11868868
    Abstract: Disclosed is a method for implementing an adaptive stochastic spiking neuron based on a ferroelectric field effect transistor, relating to the technical field of spiking neurons in neuromorphic computing. Hardware in the method includes a ferroelectric field effect transistor (fefet), an n-type mosfet, and an l-fefet formed by enhancing a polarization degradation characteristic of a ferroelectric material for the ferroelectric field-effect transistor, wherein a series structure of the fefet and the n-type mosfet adaptively modulates a voltage pulse signal transmitted from a synapse. The l-fefet has a gate terminal connected to a source terminal of the fefet to receive the modulated pulse signal, and simulates integration, leakage, and stochastic spike firing characteristics of a biological neuron, thereby implementing an advanced function of adaptive stochastic spike firing of the neuron.
    Type: Grant
    Filed: November 27, 2020
    Date of Patent: January 9, 2024
    Assignee: Peking University
    Inventors: Ru Huang, Jin Luo, Tianyi Liu, Qianqian Huang
  • Patent number: 11845774
    Abstract: The present invention pertains to pharmaceutical chemical field, and relates to a sterol derivative as well as preparation method and uses thereof. Specifically, the present invention relates to a compound of Formula I, or a pharmaceutically acceptable salt, ester or ether thereof, wherein, R1 is selected from the group consisting of —OH, ?O(carbonyl), H, and C1-C3 alkyl; R2 is selected from the group consisting of —OH, H, and C1-C3 alkyl; R3 is selected from the group consisting of —OH, ?O, H, and C1-C3 alkyl; R4 is selected from the group consisting of —OH, H, and C1-C3 alkyl; and none, one, two, three or four of R1, R2, R3, and R4 are —OH. The compound of the present invention can inhibit HMG-CoA reductase, tumor cells and lipase effectively, and is a potential drug for reducing blood-fat, antitumors, or for losing weight.
    Type: Grant
    Filed: August 8, 2022
    Date of Patent: December 19, 2023
    Assignee: Beijing Peking University WBL Biotech Co., Ltd.
    Inventors: Zhenwen Duan, Shuren Guo, Xuemei Li
  • Patent number: 11845775
    Abstract: The present invention pertains to pharmaceutical chemical field, and relates to a sterol derivative as well as preparation method and uses thereof. Specifically, the present invention relates to a compound of Formula I, or a pharmaceutically acceptable salt, ester or ether thereof, wherein, R1 is selected from the group consisting of —OH, ?O(carbonyl), H, and C1-C3 alkyl; R2 is selected from the group consisting of —OH, H, and C1-C3 alkyl; R3 is selected from the group consisting of —OH, ?O, H, and C1-C3 alkyl; R4 is selected from the group consisting of —OH, H, and C1-C3 alkyl; and none, one, two, three or four of R1, R2, R3, and R4 are —OH. The compound of the present invention can inhibit HMG-CoA reductase, tumor cells and lipase effectively, and is a potential drug for reducing blood-fat, antitumors, or for losing weight.
    Type: Grant
    Filed: August 9, 2022
    Date of Patent: December 19, 2023
    Assignee: Beijing Peking University WBL Biotech Co., Ltd.
    Inventors: Zhenwen Duan, Shuren Guo, Xuemei Li
  • Patent number: 11840582
    Abstract: The present disclosure relates to a method of synthesizing cyclosporine derivatives. The method includes: providing a precursor fluid of the cyclosporine derivative, an alkaline fluid and a ClCH2OCOCl solution; premixing the precursor fluid and the alkaline fluid to obtain a premixed solution; feeding the premixed solution into a first reaction chamber, reacting to prepare a first reaction liquid; feeding the first reaction liquid into a second reaction chamber, reacting the first reaction liquid with a CO2 fluid to prepare a second reaction liquid; and reacting the second reaction liquid with the ClCH2OCOCl solution.
    Type: Grant
    Filed: July 12, 2021
    Date of Patent: December 12, 2023
    Assignee: Peking University Shenzhen Graduate School
    Inventors: Zhen Yang, Qingzhou Zhang, Fengxia Li, Chongguo Jiang, Jianxian Gong, Jun Huang, Weibin Zhang
  • Patent number: 11841304
    Abstract: A device and method for testing an effective diffusion coefficient of helium in helium-bearing natural gas solves the problem that there is currently no systematic method or supporting experimental device to quantitatively characterize the diffusion behavior of helium in helium-bearing natural gas. The device includes a diffusion system and a gas sampling and analysis system. The diffusion system includes an upstream diffusion chamber, a downstream diffusion chamber, and a true triaxial apparatus, and is configured to simulate a gas diffusion process. The gas sampling and analysis system includes an upstream gas sample retention chamber, a downstream gas sample retention chamber, and a chromatographic analyzer, and is configured to sample a diffusing gas and analyze composition of the gas. By performing diffusion process simulation, gas sampling and analysis, and data calculation and fitting, the effective diffusion coefficient of helium in the helium-bearing natural gas is finally acquired.
    Type: Grant
    Filed: July 19, 2023
    Date of Patent: December 12, 2023
    Assignee: Peking University
    Inventors: Quanyou Liu, Pengpeng Li, Yu Gao
  • Publication number: 20230360256
    Abstract: The present application relates to the technical field of deep learning and pose estimation, and more particularly, to a contextual instance decoupling (CID)-based multi-person pose estimation (MPPE) method and apparatus. The method includes: acquiring a preset number of images containing multiple persons; inputting the images containing multiple persons, as a training sample, into a CID-based MPPE model for training; and performing pose estimation on a target image using the trained CID-based MPPE model, the CID-based MPPE model being provided with an instance information abstraction module, a global feature decoupling module and a heatmap estimation module. The method and apparatus of the present application can explore context clues over a greater range, thus being robust to spatial detection errors and superior in both accuracy and efficiency.
    Type: Application
    Filed: December 27, 2022
    Publication date: November 9, 2023
    Applicant: Peking University
    Inventors: Shiliang ZHANG, Dongkai WANG
  • Publication number: 20230330326
    Abstract: The present disclosure relates to the technical field of electroosmotic pumps (EOPs) and wearable medical equipment, and in particular, to an EOP, an insulin pump and an insulin pump system. The EOP of the present disclosure is cost-effective and has low power consumption, and can replace an existing mechanical pump device as a driving device in the insulin pump to achieve miniaturization of the insulin pump and lower the price of the insulin pump. In addition, when the EOP adopts a modified flexible membrane with penetrating pores, the EOP can pump and infuse a high-concentration insulin solution to achieve miniaturization and high efficiency of the insulin pump, which is conducive to the integration of wearable medical devices for treating diabetes.
    Type: Application
    Filed: January 12, 2023
    Publication date: October 19, 2023
    Applicant: Peking University
    Inventor: Yue CUI
  • Patent number: 11736224
    Abstract: This application provides a data transmission method. The method includes: An electronic device first establishes an MPTCP connection to an application server, where the MPTCP connection includes two TCP connections. Then, the electronic device receives indication information from an application server, where the indication information includes a type identifier and a parameter. When the type identifier indicates a low data transmission delay requirement, the electronic device receives, in a first time period after the electronic device receives the indication information, the data stream by using a first TCP connection. When an accumulated data amount actually received by the electronic device in the first time period is less than a product of the parameter and duration corresponding to the first time period, the electronic device receives the data stream in a second time period by using both the two TCP connections.
    Type: Grant
    Filed: December 10, 2019
    Date of Patent: August 22, 2023
    Assignees: Huawei Technologies Co., Ltd., Peking University
    Inventors: Hao Wang, Chenren Xu, Shuo Chen, Jianfeng Qi, Henghui Liang, Xiaojin Li, Lili Liu, Guan Wang
  • Publication number: 20230168218
    Abstract: A sensor array device includes a substrate and electrodes. The electrodes include a power electrode located in a first region of the substrate and a plurality of working electrodes located in a second region of the substrate. Surfaces of the working electrodes have various specific enzymes, respectively, and the specific enzymes on the surfaces of the working electrodes are different. The plurality of working electrodes are located in different sub-regions of the second region, respectively. The sensor array device further includes a guide layer or a hydrophilic layer. The guide layer is located above the electrodes and covers the first region and the second region. An edge of the guide layer extends to an edge of the substrate. The hydrophilic layer is arranged on the substrate and covers the first region and the second region, and an edge of the hydrophilic layer extends to the edge of the substrate.
    Type: Application
    Filed: November 25, 2022
    Publication date: June 1, 2023
    Applicant: Peking University
    Inventor: Yue CUI
  • Publication number: 20230157996
    Abstract: The present application provides a small-molecule inhibitor targeting an EB virus nuclear antigen protein, and/or a pharmaceutical composition containing the same, which can be used for the treatment of a disease caused by EBNA1 activity, such as, but not limited to, cancer, infectious mononucleosis, chronic fatigue syndrome, multiple sclerosis, systemic lupus erythematosus and/or rheumatoid arthritis. The present application further provides a small-molecule inhibitor targeting an EB virus nuclear antigen protein, and/or a pharmaceutical composition containing the same, which can be used for the treatment of a disease caused by EBV infection in a lytic and/or latent phase.
    Type: Application
    Filed: December 2, 2022
    Publication date: May 25, 2023
    Applicants: Shenzhen Bay Laboratory, Peking University Shenzhen Graduate School
    Inventors: Zhendong ZHU, Zhengshuang XU, Ting LI, Chao CHE, Qingzhou ZHANG, Sigui CHEN, Huangcan CHEN, Dehu XIANG, Zhen YANG
  • Publication number: 20230143813
    Abstract: A compound of Formula I compound—Ovatodiolide which is safe and effective to use in a pharmaceutical composition for inhibition of SARS-CoV-2 is provided. The pharmaceutical composition comprising a safe and effective amount of a compound of Formula I compound—Ovatodiolide or pharmaceutically acceptable salts thereof, together with a pharmaceutically acceptable carrier, which has great potential to treat SARS-CoV-2 induced COVID-19 based on a safe and effective amount of a compound of Formula I compound—Ovatodiolide.
    Type: Application
    Filed: April 17, 2020
    Publication date: May 11, 2023
    Applicants: Peking University Shenzhen Graduate School, CNS Biotek Corp., Gansu Evergreen Pharmaceuticals, Co., Ltd.
    Inventors: Zhen Yang, Yew-Min Tzeng, Linqi Zhang, Junmin Quan, Qing Chang, Qi Zhang, Chien-Ming Lee